Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Y. Noda, S. Motoyama, S. Nakamura, M. Shimazawa, H. Hara

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease caused by the loss of upper and lower motor neurons resulting in muscle weakness and paralysis. Recently, VGF, a neuropeptide that is a precursor of bioactive polypeptides, was found to be decreased in ALS patients, and its inducer exerted protective effects in models of ALS. These findings suggested that VGF was involved in the pathology of ALS. Here, we investigated the neuroprotective effects of various VGF-derived peptides in an in vitro ALS model. We applied seven VGF-derived peptides (TLQP-21, AQEE-30, AQEE-11, LQEQ-19, QEEL-16, LENY-13, and HVLL-7) to the motor neuron-derived cell line, NSC-34, expressing SOD1G93A, which is one of the mutated proteins responsible for familial ALS. Nuclear staining revealed that AQEE-30 and LQEQ-19, which are derived from the C-terminal polypeptide of the VGF precursor protein, attenuated neuronal cell death. Furthermore, immunoblot analysis demonstrated that LQEQ-19 promoted the phosphorylation of Akt and extracellular signal-regulated kinase (ERK) 1/2, and inhibiting these mitogen-activated MAP kinases (MAPKs) with phosphoinositide 3-kinase or MEK/ERK inhibitors, eliminated the neuroprotective effects of LQEQ-19. In conclusion, these results suggest that VGF C-terminal peptides exert their neuroprotective effects via activation of MAPKs such as Akt and ERK1/2. Furthermore, these findings indicate that VGF-derived peptides have potential application in ALS therapy. More... »

PAGES

897-904

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11064-019-02725-4

DOI

http://dx.doi.org/10.1007/s11064-019-02725-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111498671

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30656593


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Gifu Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411697.c", 
          "name": [
            "Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noda", 
        "givenName": "Y.", 
        "id": "sg:person.0653035147.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653035147.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411697.c", 
          "name": [
            "Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Motoyama", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411697.c", 
          "name": [
            "Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "S.", 
        "id": "sg:person.01317601615.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317601615.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411697.c", 
          "name": [
            "Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimazawa", 
        "givenName": "M.", 
        "id": "sg:person.01136611255.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136611255.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411697.c", 
          "name": [
            "Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "H.", 
        "id": "sg:person.0710456250.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710456250.87"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1074/jbc.m113.497214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001062907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/prp2.140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001360134"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/jcbfm.2011.155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003474597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/jcbfm.2011.155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003474597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0164689", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004373317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0079760", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005279570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neulet.2010.11.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007645094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0109305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008412190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12263-009-0110-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013231141", 
          "https://doi.org/10.1007/s12263-009-0110-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12263-009-0110-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013231141", 
          "https://doi.org/10.1007/s12263-009-0110-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.brainres.2008.02.073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018762620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.0293-12.2012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020343284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuroscience.2007.08.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020681549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3410/b3-18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021222218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m113.510917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021334742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/joe-10-0189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025257540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fendo.2015.00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025687976"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.5987-09.2010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032881292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2005.05.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032911895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2005.05.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032911895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/joe.0.1790227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034932019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/joe.0.1790227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034932019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12035-015-9165-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035560327", 
          "https://doi.org/10.1007/s12035-015-9165-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12035-015-9165-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035560327", 
          "https://doi.org/10.1007/s12035-015-9165-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bph.12277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036266165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-3940(95)98235-p", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045138706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1471-4159.2002.00842.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047383623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.1127-09.2009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049754408"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0015307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052427107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7150/ijms.5.92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073619269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.23-34-10800.2003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076604329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.09-12-04122.1989", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079025050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0172724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083896548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fphar.2017.00167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084434087"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/ijms18030612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084435908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fncel.2017.00158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085748837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/mp.2017.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092804821", 
          "https://doi.org/10.1038/mp.2017.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/mp.2017.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092804821", 
          "https://doi.org/10.1038/mp.2017.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/mp.2017.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092804821", 
          "https://doi.org/10.1038/mp.2017.233"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease caused by the loss of upper and lower motor neurons resulting in muscle weakness and paralysis. Recently, VGF, a neuropeptide that is a precursor of bioactive polypeptides, was found to be decreased in ALS patients, and its inducer exerted protective effects in models of ALS. These findings suggested that VGF was involved in the pathology of ALS. Here, we investigated the neuroprotective effects of various VGF-derived peptides in an in vitro ALS model. We applied seven VGF-derived peptides (TLQP-21, AQEE-30, AQEE-11, LQEQ-19, QEEL-16, LENY-13, and HVLL-7) to the motor neuron-derived cell line, NSC-34, expressing SOD1G93A, which is one of the mutated proteins responsible for familial ALS. Nuclear staining revealed that AQEE-30 and LQEQ-19, which are derived from the C-terminal polypeptide of the VGF precursor protein, attenuated neuronal cell death. Furthermore, immunoblot analysis demonstrated that LQEQ-19 promoted the phosphorylation of Akt and extracellular signal-regulated kinase (ERK) 1/2, and inhibiting these mitogen-activated MAP kinases (MAPKs) with phosphoinositide 3-kinase or MEK/ERK inhibitors, eliminated the neuroprotective effects of LQEQ-19. In conclusion, these results suggest that VGF C-terminal peptides exert their neuroprotective effects via activation of MAPKs such as Akt and ERK1/2. Furthermore, these findings indicate that VGF-derived peptides have potential application in ALS therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11064-019-02725-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085962", 
        "issn": [
          "0364-3190", 
          "1573-6903"
        ], 
        "name": "Neurochemical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "name": "Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis", 
    "pagination": "897-904", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "912c8380bb4bbb8414eab56169544785fbc4532e656399bedc405de1a3507138"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30656593"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7613461"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11064-019-02725-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111498671"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11064-019-02725-4", 
      "https://app.dimensions.ai/details/publication/pub.1111498671"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000370_0000000370/records_46757_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11064-019-02725-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11064-019-02725-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11064-019-02725-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11064-019-02725-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11064-019-02725-4'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      61 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11064-019-02725-4 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author Na2d3324645fd43a8b22072ec9aa8167e
4 schema:citation sg:pub.10.1007/s12035-015-9165-7
5 sg:pub.10.1007/s12263-009-0110-0
6 sg:pub.10.1038/mp.2017.233
7 https://doi.org/10.1002/prp2.140
8 https://doi.org/10.1016/0304-3940(95)98235-p
9 https://doi.org/10.1016/j.brainres.2008.02.073
10 https://doi.org/10.1016/j.neulet.2010.11.008
11 https://doi.org/10.1016/j.neuropharm.2005.05.015
12 https://doi.org/10.1016/j.neuroscience.2007.08.029
13 https://doi.org/10.1038/jcbfm.2011.155
14 https://doi.org/10.1046/j.1471-4159.2002.00842.x
15 https://doi.org/10.1074/jbc.m113.497214
16 https://doi.org/10.1074/jbc.m113.510917
17 https://doi.org/10.1111/bph.12277
18 https://doi.org/10.1371/journal.pone.0015307
19 https://doi.org/10.1371/journal.pone.0079760
20 https://doi.org/10.1371/journal.pone.0109305
21 https://doi.org/10.1371/journal.pone.0164689
22 https://doi.org/10.1371/journal.pone.0172724
23 https://doi.org/10.1523/jneurosci.0293-12.2012
24 https://doi.org/10.1523/jneurosci.09-12-04122.1989
25 https://doi.org/10.1523/jneurosci.1127-09.2009
26 https://doi.org/10.1523/jneurosci.23-34-10800.2003
27 https://doi.org/10.1523/jneurosci.5987-09.2010
28 https://doi.org/10.1677/joe-10-0189
29 https://doi.org/10.1677/joe.0.1790227
30 https://doi.org/10.3389/fendo.2015.00003
31 https://doi.org/10.3389/fncel.2017.00158
32 https://doi.org/10.3389/fphar.2017.00167
33 https://doi.org/10.3390/ijms18030612
34 https://doi.org/10.3410/b3-18
35 https://doi.org/10.7150/ijms.5.92
36 schema:datePublished 2019-04
37 schema:datePublishedReg 2019-04-01
38 schema:description Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease caused by the loss of upper and lower motor neurons resulting in muscle weakness and paralysis. Recently, VGF, a neuropeptide that is a precursor of bioactive polypeptides, was found to be decreased in ALS patients, and its inducer exerted protective effects in models of ALS. These findings suggested that VGF was involved in the pathology of ALS. Here, we investigated the neuroprotective effects of various VGF-derived peptides in an in vitro ALS model. We applied seven VGF-derived peptides (TLQP-21, AQEE-30, AQEE-11, LQEQ-19, QEEL-16, LENY-13, and HVLL-7) to the motor neuron-derived cell line, NSC-34, expressing SOD1<sup>G93A</sup>, which is one of the mutated proteins responsible for familial ALS. Nuclear staining revealed that AQEE-30 and LQEQ-19, which are derived from the C-terminal polypeptide of the VGF precursor protein, attenuated neuronal cell death. Furthermore, immunoblot analysis demonstrated that LQEQ-19 promoted the phosphorylation of Akt and extracellular signal-regulated kinase (ERK) 1/2, and inhibiting these mitogen-activated MAP kinases (MAPKs) with phosphoinositide 3-kinase or MEK/ERK inhibitors, eliminated the neuroprotective effects of LQEQ-19. In conclusion, these results suggest that VGF C-terminal peptides exert their neuroprotective effects via activation of MAPKs such as Akt and ERK1/2. Furthermore, these findings indicate that VGF-derived peptides have potential application in ALS therapy.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree false
42 schema:isPartOf N572ce1e37db846ecbfc9b8a749f83ee7
43 Nd5ebafe20ab244cc9718beeeb92f1650
44 sg:journal.1085962
45 schema:name Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis
46 schema:pagination 897-904
47 schema:productId N044a57dd2db44f329eea8b8bafcc827e
48 N34503261d4464bb3b142d6747ef5b49e
49 N362aea75153b491eb541e0b4ac7a6858
50 N928d16dd7d7440b19cdb2edc76248782
51 Nb1883d5a376746d3870f550e385bd4b5
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111498671
53 https://doi.org/10.1007/s11064-019-02725-4
54 schema:sdDatePublished 2019-04-11T13:31
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N9144a5fa36c6409bb428d9a1345da4a7
57 schema:url https://link.springer.com/10.1007%2Fs11064-019-02725-4
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N044a57dd2db44f329eea8b8bafcc827e schema:name dimensions_id
62 schema:value pub.1111498671
63 rdf:type schema:PropertyValue
64 N2588d30509f04579b116ebef22307d56 rdf:first N5dab716ecb5141bfa1991fdea32f0614
65 rdf:rest Nec3afd342a5b4c9fbe7c4cc5a4129ab9
66 N34503261d4464bb3b142d6747ef5b49e schema:name nlm_unique_id
67 schema:value 7613461
68 rdf:type schema:PropertyValue
69 N362aea75153b491eb541e0b4ac7a6858 schema:name doi
70 schema:value 10.1007/s11064-019-02725-4
71 rdf:type schema:PropertyValue
72 N572ce1e37db846ecbfc9b8a749f83ee7 schema:issueNumber 4
73 rdf:type schema:PublicationIssue
74 N5dab716ecb5141bfa1991fdea32f0614 schema:affiliation https://www.grid.ac/institutes/grid.411697.c
75 schema:familyName Motoyama
76 schema:givenName S.
77 rdf:type schema:Person
78 N77df3698a6c941c8a114e0c75f36e322 rdf:first sg:person.01136611255.99
79 rdf:rest Nce32f1b4727043e4b7203a097b9b0521
80 N9144a5fa36c6409bb428d9a1345da4a7 schema:name Springer Nature - SN SciGraph project
81 rdf:type schema:Organization
82 N928d16dd7d7440b19cdb2edc76248782 schema:name readcube_id
83 schema:value 912c8380bb4bbb8414eab56169544785fbc4532e656399bedc405de1a3507138
84 rdf:type schema:PropertyValue
85 Na2d3324645fd43a8b22072ec9aa8167e rdf:first sg:person.0653035147.28
86 rdf:rest N2588d30509f04579b116ebef22307d56
87 Nb1883d5a376746d3870f550e385bd4b5 schema:name pubmed_id
88 schema:value 30656593
89 rdf:type schema:PropertyValue
90 Nce32f1b4727043e4b7203a097b9b0521 rdf:first sg:person.0710456250.87
91 rdf:rest rdf:nil
92 Nd5ebafe20ab244cc9718beeeb92f1650 schema:volumeNumber 44
93 rdf:type schema:PublicationVolume
94 Nec3afd342a5b4c9fbe7c4cc5a4129ab9 rdf:first sg:person.01317601615.02
95 rdf:rest N77df3698a6c941c8a114e0c75f36e322
96 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
97 schema:name Medical and Health Sciences
98 rdf:type schema:DefinedTerm
99 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
100 schema:name Neurosciences
101 rdf:type schema:DefinedTerm
102 sg:journal.1085962 schema:issn 0364-3190
103 1573-6903
104 schema:name Neurochemical Research
105 rdf:type schema:Periodical
106 sg:person.01136611255.99 schema:affiliation https://www.grid.ac/institutes/grid.411697.c
107 schema:familyName Shimazawa
108 schema:givenName M.
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136611255.99
110 rdf:type schema:Person
111 sg:person.01317601615.02 schema:affiliation https://www.grid.ac/institutes/grid.411697.c
112 schema:familyName Nakamura
113 schema:givenName S.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317601615.02
115 rdf:type schema:Person
116 sg:person.0653035147.28 schema:affiliation https://www.grid.ac/institutes/grid.411697.c
117 schema:familyName Noda
118 schema:givenName Y.
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653035147.28
120 rdf:type schema:Person
121 sg:person.0710456250.87 schema:affiliation https://www.grid.ac/institutes/grid.411697.c
122 schema:familyName Hara
123 schema:givenName H.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710456250.87
125 rdf:type schema:Person
126 sg:pub.10.1007/s12035-015-9165-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035560327
127 https://doi.org/10.1007/s12035-015-9165-7
128 rdf:type schema:CreativeWork
129 sg:pub.10.1007/s12263-009-0110-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013231141
130 https://doi.org/10.1007/s12263-009-0110-0
131 rdf:type schema:CreativeWork
132 sg:pub.10.1038/mp.2017.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092804821
133 https://doi.org/10.1038/mp.2017.233
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1002/prp2.140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001360134
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/0304-3940(95)98235-p schema:sameAs https://app.dimensions.ai/details/publication/pub.1045138706
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/j.brainres.2008.02.073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018762620
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.neulet.2010.11.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007645094
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.neuropharm.2005.05.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032911895
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.neuroscience.2007.08.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020681549
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1038/jcbfm.2011.155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003474597
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1046/j.1471-4159.2002.00842.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047383623
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1074/jbc.m113.497214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001062907
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1074/jbc.m113.510917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021334742
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1111/bph.12277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036266165
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1371/journal.pone.0015307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052427107
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1371/journal.pone.0079760 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005279570
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1371/journal.pone.0109305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008412190
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1371/journal.pone.0164689 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004373317
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1371/journal.pone.0172724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083896548
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1523/jneurosci.0293-12.2012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020343284
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1523/jneurosci.09-12-04122.1989 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079025050
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1523/jneurosci.1127-09.2009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049754408
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1523/jneurosci.23-34-10800.2003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076604329
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1523/jneurosci.5987-09.2010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032881292
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1677/joe-10-0189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025257540
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1677/joe.0.1790227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034932019
180 rdf:type schema:CreativeWork
181 https://doi.org/10.3389/fendo.2015.00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025687976
182 rdf:type schema:CreativeWork
183 https://doi.org/10.3389/fncel.2017.00158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085748837
184 rdf:type schema:CreativeWork
185 https://doi.org/10.3389/fphar.2017.00167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084434087
186 rdf:type schema:CreativeWork
187 https://doi.org/10.3390/ijms18030612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084435908
188 rdf:type schema:CreativeWork
189 https://doi.org/10.3410/b3-18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021222218
190 rdf:type schema:CreativeWork
191 https://doi.org/10.7150/ijms.5.92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073619269
192 rdf:type schema:CreativeWork
193 https://www.grid.ac/institutes/grid.411697.c schema:alternateName Gifu Pharmaceutical University
194 schema:name Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, 501-1196, Gifu, Japan
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...